Vaccination in horses involves the administration of biological preparations designed to stimulate the equine immune system to recognize and combat specific pathogens. Vaccines are formulated to prevent or reduce the severity of infectious diseases that can affect equine health and performance. Common vaccines for horses include those for equine influenza, tetanus, equine herpesvirus, and West Nile virus. The administration schedule and type of vaccine can vary based on factors such as geographic location, age, and use of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in horses, as well as their impact on equine health management.
Equine rabies is a sporadic but highly fatal zoonotic disease. The disease persists in wildlife populations throughout the United States, Canada, Mexico, and other parts of the world. It remains a threat to all domestic species, including the horse. This article reports recent advances in the molecular virology of the rabies virus and its pathogenesis, and it also reviews the history, clinical signs, diagnostic tests, vaccination protocols, and postexposure management recommendations for the equine species.
A clinical evaluation of a new, purified, heat-treated equine rabies immunoglobulin (PHT-Erig), F(ab')2 preparation, was carried out in Thailand and in the Philippines-two countries where rabies is endemic. An initial prospective, randomised, controlled trial (Study 1), compared the safety and pharmacokinetics (serum concentrations of rabies antibodies) after administration either of PHT-Erig or of a commercially-available, equine rabies immune globulin (Erig PMC). A second trial (Study 2) simulated post-exposure rabies prophylaxis by using a reference cell culture vaccine, the purified Vero-c...
Naveed A, Eertink LG, Soni S, Kennedy MA, Adam E, Wang D, Li F.Equine rotavirus A (ERVA) poses a significant threat to foal health, necessitating reliable serological tools for assessing protective immune responses. This study focused on the development of an enzyme-linked immunosorbent assay (ELISA) for the measurement of antibodies against the VP8∗ receptor binding core domain of ERVA. Following the expression and purification of VP8∗ receptor binding domain from the bacterial expression system, the ELISA for detecting anti-ERVA VP8∗ antibodies with VP8∗ as a coating antigen was developed and its performance was validated by the comparative anal...
Jiang Z, Merits A, Qin Y, Xing G, Zhang L, Chen J, Wang N, Varjak M, Zhai X, Li D, Song W, Su S.Alphaviruses are important arthropod-transmitted pathogens of humans and livestock. Getah virus (GETV) is an arthritogenic alphavirus that causes disease in horses and piglets; it also poses a potential threat to humans. A live attenuated vaccine candidate named GETV-3ΔS2-CM1, harbouring a deletion in nonstructural protein 3 and substitutions in the capsid protein, is genetically stable and exhibits robust immunogenicity. It was shown to confer passive protection to piglets born to immunized sows. In mice, a single dose of GETV-3ΔS2-CM1 protected against infection with different strains of G...